|
|
|
|
|
|
Today, cancer remains one of Europe’s leading causes of death and disability, accounting for 23 percent of all deaths in 2022 and 17 percent of disability-adjusted life years in 2021. Four Europeans are diagnosed with cancer every minute, a number that is expected to rise over the next several decades due to population aging. As the EU Beating Cancer Plan reaches the end of its initial phase, Europe now stands at a critical moment. The question is not whether progress has been made, but whether Europe will build on that momentum or allow it to stall, with consequences not only for health outcomes, but also for economic growth and scientific leadership.
|
|||||
|
|
The EFPIA Oncology Platform will today launch its new White Paper, at a high-level policy event in Toledo, Spain, organised in collaboration with Farmaindustria. The paper calls for more coordinated action to reduce persistent disparities in access to targeted cancer treatments and biomarker testing across Europe. The White Paper, entitled “Advancing precision oncology treatment and testing across Europe: An evidence-based roadmap for healthcare system stakeholders to improve cancer care”, brings together policymakers, clinicians, patient representatives, payers, industry leaders and regional and national health stakeholders to discuss how to translate scientific progress in a more targeted and personalized treatment of cancer into equitable access for patients.
Read the White Paper here. |
|
|
27 February 2026
Impact of Innovative Medicines/Health Initatives projects on rare diseases
Rare diseases present unique scientific, clinical and economic challenges, and through IMI and IHI public-private partnerships,...
|
||
|
|
IHI: Lifting the lid on in-kind contributions
Online
Discover how in-kind contributions from industry are key to the success of IHI projects, allowing them to deliver results... Learn more → |
|||
|
Improving Europe’s water quality - How can the revised UWWTD be implemented fairly...
Brussles, Belgium
Join this Euractiv Hybrid Conference to explore how the revised Urban Wastewater Treatment Directive and its EPR scheme... Learn more → |
|||
|
J&J | The essentials of partnering with a pharma company
Utrecht & Virtual
Discover what it takes to build successful collaborations with pharmaceutical companies and accelerate your innovation... Learn more → |
|||
|
Europe’s Choice: Investing in sustainable health systems
Brussels, Belgium
At a time when health budgets are strained, public finances are under pressure, the health workforce crisis is deepening,... Learn more → |
|||
|
|
Minister McEntee discusses the trade and competitiveness agenda for the EU Presidency with...
04 March 2026 (gov.ie)
Minister for Foreign Affairs and Trade, Helen McEntee TD, today met with representatives of the European Federation...
|
|
Turning the tide on cardiovascular diseases
03 March 2026 (Vaccines Europe)
Cardiovascular diseases (CVD) claim over 1.8 million lives across Europe every year. Behind this number are millions...
|
|
EU Regulatory reforms and global healthcare innovation to be focus of DIA Europe 2026
03 March 2026 (Business wire)
As Europe’s leading multistakeholder conference, DIA Europe will bring together over 300 speakers from more than...
|
|
Amid unfolding Middle East war, pharma giants keep close eye on employee safety, supply chains...
02 March 2026 (Fierce Pharma)
As the effects of the United States and Israel’s weekend attack on Iran begin to ripple through the Middle East at...
|
|
|||
|
|||||
|
EFPIA 2026 All rights reserved ·
Disclaimer
·
|